These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9713596)

  • 41. [Techniques for detection of telomerase activity in tissue samples. Diagnostic and prognosis importance].
    Brousset P; al Saati T; Chaouche N; Zenou RC; Mazerolles C; Delsol G
    Ann Pathol; 1997 Oct; 17(5):364-8. PubMed ID: 9471158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase activity and its inhibition in benign and malignant breast lesions.
    Sugino T; Yoshida K; Bolodeoku J; Tarin D; Goodison S
    J Pathol; 1997 Sep; 183(1):57-61. PubMed ID: 9370948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
    Fajkus J
    Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chondrosarcoma is not characterized by detectable telomerase activity.
    Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ddTRAP: A Method for Sensitive and Precise Quantification of Telomerase Activity.
    Ludlow AT; Shelton D; Wright WE; Shay JW
    Methods Mol Biol; 2018; 1768():513-529. PubMed ID: 29717462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of telomerase activity in high concentration of cell lysates using primer-modified gold nanoparticles.
    Xiao Y; Dane KY; Uzawa T; Csordas A; Qian J; Soh HT; Daugherty PS; Lagally ET; Heeger AJ; Plaxco KW
    J Am Chem Soc; 2010 Nov; 132(43):15299-307. PubMed ID: 20932008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of telomeres and telomerase.
    Herbert BS; Shay JW; Wright WE
    Curr Protoc Cell Biol; 2003 Nov; Chapter 18():Unit 18.6. PubMed ID: 18228424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomerase: is it the future diagnostic and prognostic tool in human cancer?
    Mabruk MJ; O'Flatharta C
    Expert Rev Mol Diagn; 2005 Nov; 5(6):907-16. PubMed ID: 16255632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
    Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S
    Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP).
    Jiang S; Tang M; Xin H; Huang J
    Methods Mol Biol; 2017; 1587():95-101. PubMed ID: 28324501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-radioactive assay methods for the assessment of telomerase activity and telomere length.
    Banerjee PP; Jagadeesh S
    Methods Mol Biol; 2015; 1288():305-16. PubMed ID: 25827887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telomerase activity in head and neck cancer.
    Kunická Z; Mucha I; Fajkus J
    Anticancer Res; 2008; 28(5B):3125-9. PubMed ID: 19031968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
    Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.
    Jakupciak JP; Wang W; Barker PE; Srivastava S; Atha DH
    J Mol Diagn; 2004 Aug; 6(3):157-65. PubMed ID: 15269291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.
    Yashima K; Piatyszek MA; Saboorian HM; Virmani AK; Brown D; Shay JW; Gazdar AF
    J Clin Pathol; 1997 Feb; 50(2):110-7. PubMed ID: 9155690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
    Segawa N; Gohji K; Azuma H; Iwamoto Y; Ohnishi K; Katsuoka Y
    Int J Urol; 2003 Mar; 10(3):153-9. PubMed ID: 12622712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.